IPRIPR2024-01312Terminated
Biofrontera Incorporated et al.v.Sun Pharmaceutical Industries, Inc.
IPR challenge of US 11697028.
Type
IPR
Filed
Aug 21, 2024
Instituted
Feb 24, 2025
Decided
Jul 29, 2026
Patent
Application
17942353
Inventor
Thomas BOYAJIAN et al
Granted
Jul 11, 2023
01
Timeline
3 milestones
2024-08-21Petition filed
2025-02-24Institution
2026-07-29Terminated
02
Parties & counsel
Petitioner
Biofrontera Incorporated et al.
Counsel
Murphy, Jameset al
Patent Owner
Sun Pharmaceutical Industries, Inc.
Counsel
Higgins, Gabrielleet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →